Back to Search
Start Over
rSodC is a potential antigen to diagnose Corynebacterium pseudotuberculosis by enzyme-linked immunoassay
- Source :
- Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP, AMB Express, Vol 10, Iss 1, Pp 1-8 (2020), AMB Express
- Publication Year :
- 2020
-
Abstract
- Made available in DSpace on 2021-06-25T11:05:31Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-12-01 Caseous lymphadenitis (CL) is a chronic infectious disease that affects sheep and goats. Many serological tests have been developed to detect the disease; one of the most widely used is the enzyme-linked immunosorbent assay (ELISA), due to its advantages, which include acceptable cost-effectiveness, applicability, sensitivity and specificity. ELISA formulations using recombinant proteins can exhibit significant sensitivity and specificity when using a single purified antigen. DTxR, Trx, TrxR, LexA, SodC, SpaC, NanH, and PknG recombinant proteins can be considered target proteins for ELISA development due to its extracellular or on the cell surface location, which allows a better recognition by the immune system. Therefore, the objectives of this study were to evaluate the antigenic reactivity of Corynebacterium pseudotuberculosis recombinant proteins in goat and sheep serum. Of eight proteins evaluated, rSodC was selected for validation assays with small ruminant serum samples from the semiarid region of the state of Bahia, Brazil. Validation assays with goat serum samples showed that ELISA-rSodC presented sensitivity and specificity of 96% and 94%, respectively. Validation assays with sheep serum showed that ELISA-rSodC exhibited sensitivity and specificity of 95% and 98%, respectively. Analysis of 756 field serum samples showed that rSodC identified 95 positive samples (23%) in goats and 75 positive samples (21%) in sheep. The ELISA with recombinant SodC protein developed in this study discriminated positive and negative serum samples with high levels of sensitivity and specificity. This formulation is promising for epidemiological surveys and CL control programs. Trial registration AEC No 4958051018. 12/18/2018, retrospectively registered Immunology and Molecular Biology Laboratory (LABIMUNO) Federal University of Bahia (UFBA) College of Science and Entrepreneurship (FACEMP) Feira de Santana State University (UEFS) Multiuser Center for Biomolecular Innovation (IBILCE/UNESP) Multiuser Center for Biomolecular Innovation (IBILCE/UNESP)
- Subjects :
- Corynebacterium pseudotuberculosis
lcsh:Biotechnology
Biophysics
lcsh:QR1-502
Biology
Applied Microbiology and Biotechnology
lcsh:Microbiology
law.invention
Microbiology
Serology
03 medical and health sciences
Immune system
Antigen
law
lcsh:TP248.13-248.65
Extracellular
Caseous lymphadenitis
030304 developmental biology
0303 health sciences
030306 microbiology
SodC recombinant protein
Recombinant DNA
Original Article
ELISA
Repressor lexA
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP, AMB Express, Vol 10, Iss 1, Pp 1-8 (2020), AMB Express
- Accession number :
- edsair.doi.dedup.....362c3f37bc67cb29834973df99f6e412